Jim Cramer Says Merck & Co., Inc. (MRK) Is ‘Just Way Too Hated’

Published on 18 Nov 2024 on Insider Monkey · via Yahoo Finance

We recently compiled a list of the Jim Cramer Talked About These 11 Stocks Recently. In this...

Read the rest of the article

Start tracking your investments with Statfolio

For those looking for great candidates, here are two in the healthcare sector: Merck (NYSE: MRK) ...

Motley Fool · via Yahoo Finance 21 Nov 2024

A subcutaneous version of Merck’s Keytruda was as effective as the infused version in a late-stag...

Pharma Voice · via Yahoo Finance 21 Nov 2024

We recently published a list of Ken Griffin Stock Portfolio: 10 Stocks to Buy. In this article, w...

Insider Monkey · via Yahoo Finance 20 Nov 2024

Johnson & Johnson and Merck & Co. are cutting jobs in China, as they face growing competition fro...

Bloomberg 20 Nov 2024

On Tuesday, Merck & Co Inc (NYSE:MRK) revealed topline results from the pivotal Phase 3 MK-3475A-...

Benzinga · via Yahoo Finance 19 Nov 2024

Merck reported good news Tuesday on a more convenient version of its cancer drug Keytruda, a...

Barrons.com 19 Nov 2024

Keytruda, a Merck cancer immunotherapy that has become the world’s top-selling medication, is...

MedCity News 19 Nov 2024

We recently compiled a list of the Jim Cramer Talked About These 11 Stocks Recently. In this...

Insider Monkey · via Yahoo Finance 18 Nov 2024

We recently compiled a list of the 10 Best Immunotherapy Stocks to Buy Now. In this article, we a...

Insider Monkey · via Yahoo Finance 18 Nov 2024

Merck & Co.’s recent $1.3 billion deal to reel in Modifi Biosciences seemed to ignore pharma’s...

Pharma Voice · via Yahoo Finance 18 Nov 2024